Longest Studied News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Longest Studied. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Longest Studied Today - Breaking & Trending Today

AMGEN ANNOUNCES RESULTS FROM TWO OPEN LABEL EXTENSION STUDIES OF REPATHA® (EVOLOCUMAB)

Published: April 27, 2022

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced top-line results from two Repatha® (evolocumab) open label extension (OLE) studies to the Phase 3 FOURIER...

Source: prnewswire.com

Related Topics:

Puerto RicoUnited StatesMichael StrapazonJessica AkopyanAmgen MedinfoKyowa Kirin Co LtdBeigene LtdExchange CommissionTherapeutics IncEuropean UnionTeneobio IncStudies Showed Sustained ReductionCombined Studies Evaluated SafetyMore ThanOver Five Years After CompletingLongest StudiedRisk Open Label ExtensionEastern EuropeCardiovascular Open Label ExtensionDow Jones Industrial AverageBest WorkplacesGreat PlacePrimary HyperlipidemiaCardiovascular Outcomes TrialPediatric Patients